Oncternal Therapeutics, Inc.
Compounds for treatment of cancer

Last updated:

Abstract:

The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.

Status:
Grant
Type:

Utility

Filling date:

21 Feb 2019

Issue date:

10 Aug 2021